United Therapeutics | UTHR - Gross Profit On Sales


United Therapeutics reported $683.8M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Amarin USD 23.17M 961K Dec/2025
Ardelyx USD 89.66M 24.7M Mar/2026
Baxter International USD 1.14B 251M Jun/2026
Bayer EUR 8.17B 1.24B Mar/2026
BioCryst Pharmaceuticals USD 214.41M 61.36M Jun/2026
Biogen USD 2.12B 307M Jun/2026
BioMarin Pharmaceutical USD 713.42M 142.21M Jun/2026
Gilead Sciences USD 6.8B 1.29B Jun/2026
GlaxoSmithKline GBP 6.51B 757M Jun/2026
Halozyme Therapeutics USD 297.47M 75.53M Mar/2026
Insmed USD 356.19M 99.73M Jun/2026
Ionis Pharmaceuticals USD 265M 22M Jun/2026
J&J USD 18.55B 1.31B Jun/2026
Lexicon Pharmaceuticals USD 5.29M 8.88M Dec/2025
Moderna USD -566M 792M Mar/2026
Omeros USD -33.16M 18.52M Jun/2024
Pfizer USD -248M 11.29B Jun/2026
PTC Therapeutics USD 232.94M 84.56M Mar/2026
Regeneron Pharmaceuticals USD 3.71B 778.2M Jun/2026
Sangamo BioSciences -2.39M 1.09M Jun/2024
Sarepta Therapeutics USD 251.15M 370.2M Jun/2026
Teva Pharmaceutical Industries USD 2.15B 45M Jun/2026
United Therapeutics USD 683.8M 35.7M Jun/2026
Vertex Pharmaceuticals USD 2.84B 242.4M Jun/2026